USPTO – CFN Media

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 — Clearmind Medicine…

Ryan Allway
August 1, 2023

Top News

nveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin

Intellectual property describes composition of matter claims governing Enveric’s lead clinical candidate,…

Ryan Allway
May 18, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

How to Invest in the LFP Electric Battery Boom

All electric cars, whether fully electric or hybrid, need some form of…

Robin Lefferts
November 6, 2024

Top News

Introducing LEEF Brands, Vertically Integrated California Powerhouse

The cannabis industry has fallen out of favor with many investors, in…

Ryan Allway
November 1, 2024

Aduro Clean Technologies Reports Fiscal 2025 First Quarter Results

LONDON, Ontario, Oct. 31, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies…

Ryan Allway
October 31, 2024

CEO.CA Interviews Stallion Uranium CEO

Stallion Uranium Corp. (TSX.V: STUD) (OTCQB: STLNF) (FSE: FE0) CEO Drew Zimmerman…

Ryan Allway
October 29, 2024